4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+34.6%
5Y CAGR+29.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+34.6%/yr
vs +44.6%/yr prior
5Y CAGR
+29.8%/yr
Recent acceleration
Acceleration
-10.0pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $195.70M | +38.5% |
| 2024 | $141.30M | +45.5% |
| 2023 | $97.10M | +21.0% |
| 2022 | $80.25M | +30.8% |
| 2021 | $61.36M | +15.7% |
| 2020 | $53.04M | +20.9% |
| 2019 | $43.85M | +138.8% |
| 2018 | $18.36M | +35.3% |
| 2017 | $13.57M | - |